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Administration of HES in elderly patients
undergoing hip arthroplasty under spinal
anesthesia is not associated with an
increase in renal injury
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Abstract
Background: Hydroxyethyl starch (HES) is applied to achieve volume expansion during surgery; however,
nephrotoxicity may be induced in patients with sepsis. Simultaneously, neutrophil gelatinase-associated lipocalin
(NGAL) and IL-18 have been illustrated as pivotal indicators to diagnose the acute kidney injury (AKI) early. This
multi-center, randomized, double-blinded, placebo-controlled study aimed to investigate whether 6% HES 130/0.4
administration caused postoperative AKI, which can be revealed by urinary and plasma NGAL and IL-18 estimations
in elderly patients with normal renal function undergoing hip arthroplasty under spinal anesthesia.
Methods: 120 ASA I–III, patients aged >65 y undergoing hip arthroplasty under spinal anesthesia randomly received
6% HES 130/0.4 or sodium lactate Ringer’s solution 7.5 mL/kg during the first hour of surgery. 118 patients completed
the study. Blood pressure, NGAL concentrations, IL18, β2 micro-albumin and albumin in urine and creatinine, NGAL and
IL-18 in plasma were repeatedly measured before, during, and after surgery.
Results: The groups were balanced in mean arterial pressure, urine and plasma NGAL, plasma IL-18 and creatinine,
urine β2 microalbumin and albumin (P > 0.05). Urine IL-18 was dramatically elevated in both groups after
surgery (P < 0.05), but did not vary significantly between the groups (P > 0.05).
Conclusion: Elderly patients undergoing surgery under spinal anesthesia are a high-risk population in AKI.
These patients with normal renal function receiving a spinal anesthesia for a short duration surgery would not
develop AKI when 500 mL (small volume) HES is infused.
Trial registration: Identifier: NCT02361736. Registration date was 2 February 2015.
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Background
Hydroxyethyl starch (HES) is infused to sustain circula-
tion in patients undergoing surgery and suffering from
trauma and critical disease [1–3]. However, these pa-
tients may be subsequently complicated by acute kidney
injury (AKI), and HES might effectuate adverse events in
renal function. The principal detection of AKI is a rapid
increase in plasma creatinine (p-crea) or a sudden drop
in urine output [4]. Sex, age, medication, nutrition, and
muscle mass exerts a crucial effect on p-crea [5]. Simul-
taneously, the level of p-crea is upregulated at 24–48 h
after renal damage, and hence, the diagnosis of AKI is
delayed when p-crea is the sole biomarker for renal in-
jury. Remarkable progress has been made in recent years
with respect to achieving an earlier diagnosis of AKI via
the evaluation of biomarkers in urine [6]. Neutrophil
gelatinase–associated lipocalin (NGAL) is a small pro-
tein, filtered via the glomeruli and reabsorbed in the
proximal tubules, and thus, the low concentrations can
be assessed in the blood and urine [7]. Approximately
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6 h after a renal injury, NGAL experiences an abrupt up-
surge attributable to an increasing expression and secre-
tion in the epithelial cells of the thick ascending limb of
Henle’s loop, the distal tubules, and the collecting ducts
[7]. On the other hand, NGAL has been demonstrated
and substantiated to predict AKI; malignancies and in-
fections can engender a false increase [8].
Interleukin 18 (IL-18) is an18 kDa cytokine, which is
identified as a co-stimulatory factor for the generation of
interferon-γ (IFN-γ) in response to toxic shock syn-
drome. IL-18 shares functional similarities with IL-12,
and is synthesized as a 24 kDa precursor molecule with-
out a signal peptide that must be cleaved to produce an
active molecule. IL-18 is principally produced from
proximal kidney tubules and is a pro-inflammatory fac-
tor that can be detected in the urine of earlier AKI ani-
mal models. A remarkable upsurge in IL-18 levels in
urine during AKI is confirmed in several clinical studies
[9–11]. The specificity and susceptibility of IL-18 used
in AKI diagnosis is 90%. As a result, IL-18 can be chosen
as an effective biomarker to predict AKI.
Intravenous treatment with HES leads to its excretion
in urine but is also partially absorbed in the tissues
[12, 13]. Several experimental and clinical studies re-
ported that HES molecules were accumulated in the
proximal tubule cells with subsequent vacuolization
and swelling—a condition known as osmotic neph-
rosis [14–17]. Recent studies showed that the renal
function was impaired when tetrastarch was delivered
in patients with sepsis [18, 19]. However, periopera-
tive studies failed to discover the association between
AKI occurrence and HES infusion [20–23].
We hypothesized that 6% HES 130/0.4 exerted a
nephrotoxic effect in elderly patients, which could be re-
vealed by the assessment and measurements of NGAL
and IL-18 levels as a primary outcome [24]. The
hemodynamics data, plasma creatinine, urine β2 microal-
bumin, and albumin were the secondary outcomes and
also documented. The pharmacokinetic property of
Ringer’s lactated solution, different from colloids, cannot
contribute to acute kidney injury in clinics [16, 18];




The American Society of Anesthesiologists (ASA) phys-
ical status I-III of patients aged >65y scheduled for hip
arthroplasty under spinal anesthesia were contacted, in-
formed about the study, and enrolled after written con-
sent was acquired. Exclusion Criteria: any allergy and
contraindication to 6% HES 130/0.4; infections and ma-
lignancies; sepsis; history of heart failure or NYHA > III;
pre-existing renal failure or Cr >108 μmol/L, BUN
>8.3 mmol/L; undergoing dialysis treatment; intracranial
hemorrhages; long-lasting intake of any non-steroidal
anti-inflammatory agent; inability to understand the
study information sheet and provide a written consent
for participation in the study.
Intervention
Patients were randomly divided into one of the two
groups: (1) patients in group LR received intraoperative
placebo lactate Ringer’s at a dose of 7.5 mL/kg; (2) pa-
tients in group HES received 6% HES 130/0.4 at a dose
of 7.5 mL/kg during the first hour of surgery, followed
by administration of 5 mL/kg lactate Ringer’s until the
end of the surgery.
Randomization
The patients were randomly assigned to treatment
regimens via a randomization list provided by the
Department of Anesthesiology, Tianjin Medical University
General Hospital, according to the relevant Standard
Operating Procedure (computer-generated random num-
ber system). The allocation sequence was concealed until
after consent was obtained.
Blinding
The patients and a treating anesthesiologist involved in
the perioperative patient management were incognizant
of the group assignment. Primary and secondary out-
comes were measured and recorded by another
anesthesiologist responsible for data collection, but not
involved in the direct treatment of the participating pa-
tients and thus, blinded to randomization.
Procedures and outcomes
All the patients were fasting 12 h before surgery. Upon
arrival in the operation theater, the patients were
monitored by electrocardiography, pulse oximeter, and
noninvasive blood pressure. In addition, a peripheral
intravenous line in the left arm and urinary catheter
were also attached before anesthesia induction. Subse-
quent to the collection of the first blood and urine sam-
ples, the fluid was infused and mean arterial blood
pressure (MAP), heart rate (HR), and arterial saturation
were monitored. Then, Cefazolin sodium was injected at
prophylactic doses of 2 g in every patient. Spinal
anesthesia was administered to the patient in the lateral
decubitus position, side of surgery downwards, lumbar
puncture preferably midline at L3-L4 with a pencil point
25-gauge needle. 10 mg Ropivacaine was injected into
the subdural space. After 15 min, the patient was ma-
neuvered to a supine. If bradycardia (HR <45 beats/min)
and continuous hypotension (MAP <60 mmHg) persisted,
additional fluid infusion, atropine (0.5 mg) and phenyleph-
rine (0.1 mg) were also administered. Supplemental
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oxygen was provided via a nasal cannula. Hemodynamics
data was evaluated and recorded at baseline (T0), before
skin incision (T1), at skin incision (T2), after skin incision
(T3), and surgery completion (T4). A mean value at every
time point was calculated for statistical analysis.
The blood and urine samples were obtained at five
time-points: before anesthesia (D0), during surgery (D1),
the first day after surgery (D2), the third day after
surgery (D3), and the fifth day after surgery (D4). The
postoperative urine and blood samples were collected
at 8:00 a.m when patients were fasted, on D2, D3, and
D4.
All the urine and blood samples were centrifuged for
10 min at 3500 r/min at 4 °C. Consequently, the samples
were maintained at -80 °C until assayed and re-
centrifuged before usage in order to minimize any im-
purities. Every analysis was conducted consecutively by
the same laboratory technician to minimize variability in
the results.
Creatinine was measured by the sarcosine oxidase
method using the commercial kit from Nanjing
Jiancheng Bioengineering Institute. The concentration
of IL-18 in plasma and urine were assessed by Human
IL-18 ELISA Kit (Nanjing Jiancheng Bioengineering
Institute). The concentration of NGAL in plasma and
urine were measured by Human NGAL ELISA Kit
(Nanjing Jiancheng Bioengineering Institute). The urine
β2 microalbumin and trace albumin were measured by
Human β2-MG ELISA kit and Human mALB Elisa kit
(Nanjing Jiancheng Bioengineering Institute).
The estimated glomerular filtration rate (eGFR) was
documented by plasma creatinine through CKD-
EPI2009. The 24 h urinary protein quantity was altered
by the ratio of urine trace albumin and urine creatinine
(ACR). The reference interval of ACR is 0–2.5 for males
and 0–3.0 for females.
Results
A cohort of 120 patients was included. One patient was
excluded before intervention due to urine tube failure.
One patient was excluded due to hemolysis after centri-
fugation. Thus, 59 patients were allocated to the LR
group and 59 to the HES group (Fig. 1).
Age, sex, ASA, operation time, and the amount of li-
quid administered to patients, blood loss, patients need-
ing phenylephrine, phenylephrine dose per patient and
length of stay in both the groups were similar (P > 0.05,
Table 1). The two groups were comparable regarding co-
morbidities (Table 2). During the span of the entire
study, any adverse reactions were not reported.
A significant difference of MAP and HR between
T0 and T2-4 was not observed in either of the groups
(P > 0.05, Table 3). When compared with D0, the concen-
tration of IL-18 in urine was dramatically enhanced in
both the groups on D2, D3, and D4 (P < 0.05, Table 4);
however, no significant difference was seen between the
two groups. Similarly, both groups showed a balanced
plasma IL-18 at every time-point (P > 0.05, Table 4).
A remarkable alteration in the levels of eGFR, ACR,
urine and plasma NGAL, plasma creatinine, urine β2
microalbumin, and trace albumin was not noted in both
groups (P > 0.05, Table 4).
Discussion
In the current study, we investigated the influence of
intraoperative administration of lactate Ringer’s and
6% HES 130/0.4 on elderly patients with normal renal
function undergoing hip arthroplasty under spinal
anesthesia. The objective of our study was to illus-
trate whether 6% HES 130/0.4 infusion played a
nephrotoxic role that can be detected via blood pres-
sure and concentrations of NGAL, IL18, β2 microal-
bumin and albumin in urine and creatinine, as well
as, NGAL and IL-18 in plasma. The elderly patients
with normal renal function who underwent hip
arthroplasty with spinal anesthesia demonstrated that
intraoperative HES (500 mL) infusion did not cause
postoperative AKI.
A recent study suggested that utilizing HES may elicit
AKI in patients with sepsis. The current study selected
elderly patients with normal renal function to accept
spinal anesthesia and excluded the patients with infec-
tion, malignant tumors, and other factors that may affect
the level of NGAL and IL-18 in plasma and urine. We
discovered that urine IL-18 was increased significantly
and similarly in both groups post-surgery, indicating that
elderly patients are a high-risk population for the devel-
opment of AKI. Furthermore, HES is not implicated in
this process. The phenomenon in elderly patients of not
Fig. 1 Flow diagram of study
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developing AKI from the infusion of 6% HES 130/0.4
in our study might be attributed to the short duration
of surgery and the small volume of HES infusion. A
previous study suggested that AKI occurred after 36 h
when septic patients received more than 2000 mL
HES [19]. The most dramatical difference between the
recent multi-center studies (CRYSTMAS, 6S, and
CHEST) and the current investigation is the patients’
characteristics. The CHEST study by Myburgh et al.
included patients with signs of hypovolemia, the
CRYSTMAS study by Guidet et al. and the 6S trial by
Perner et al. included patients who suffered from clin-
ically defined severe sepsis. Furthermore, the vast ma-
jority of the patients in these three studies were
medical patients [18, 19, 25]. Contrastingly, the present
study exclusively investigated elderly patients with nor-
mal kidney function. Thus, we considered that 500 mL
HES would not contribute to AKI in elderly patients
who required undergoing hip arthroplasty with spinal
anesthesia.
IL-18 has been manifested as an indicator for the early
prediction of AKI. Urinary IL-18 was considerably ele-
vated for the diagnosis of AKI with sensitivity and speci-
ficity of 90%. To our knowledge, this is the first study to
discover that urine IL-18 levels were significantly in-
creased in elderly patients undergoing hip arthroplasty
under the influence of spinal anesthesia. On the other
hand, other indicators such as eGFR, ACR, plasma cre-
atinine, blood and urine NGAL, and urine β2 microglob-
ulin levels did not show a remarkable alteration.
According to the KDIGO AKI classification (the KDIGO
1 stage is a minimum increase in plasma creatinine
concentration >50% or an increase in 27 μmol/L of cre-
atinine within 48 h), all the patients in this study could
not be diagnosed as AKI. However, we are convinced
that the postoperative increase of urine IL-18 levels
might be associated with mild renal tubular damage. Im-
portantly, a significant difference in the urine level of IL-
18 between the two groups was not observed, indicating
that HES exposure is not the key reason of AKI in eld-
erly patients.
Clinical studies have reported that NGAL production
is a result of a marked immune response in the event of
AKI. Simultaneously, NGAL is an independent predictor
of AKI after sepsis, ischemia, or renal toxicity. Addition-
ally, IL-18 has been identified as specific in ischemic
AKI. We also found that IL-18 but not NGAL and other
indicators experienced a rising trend, suggesting that the
postoperative kidney damage may be due to the ischemic
effect of spinal anesthesia. Thus, according to results,
perioperative elderly patients are at high risk of ischemic
AKI, and risk of ischemia should be avoided in such
patients.
Although IL-18 was profoundly increased in both
groups, it was not a sharp rise, suggesting that all the pa-
tients in the current study developed a mild renal
inflammatory response potentially arising as a conse-
quence of the surgery or anesthesia. This mild inflam-
matory response raised the level of IL-18 in urine,
thereby increasing the load of glomerular filtration rate.
Only when the concentration of plasma IL-18 attains a
specific threshold, AKI would be generated [26]. This
may also explain why the patients in our study did not
develop AKI, and the other indicators were not signifi-
cantly increased, including NGAL.
One possible limitation of the present study is that
only the end of the operation and 1, 3, and 5 days
after operation were selected as the assessment time-
points according to the time of AKI diagnosis. A fur-
ther follow-up study on the minimal renal injury was
lacking, and thus, we could not determine when the
concentration of urine IL-18 decreased to baseline
levels [24]. In the future, additional clinical studies
with a larger volume of HES and more time-points
will be essential to substantiate the conclusion of the
present study.
Table 1 Patient characteristics and intraoperative data














HES 31/28 75.9 ± 7.5 39/15/5 56 ± 4 490 ± 30 100 ± 40 2(3.4) 0.1 ± 0.04 10.5 ± 1.7
LR 29/30 76.4 ± 8.1 37/14/8 58 ± 5 510 ± 20 120 ± 50 5(8.5) 0.15 ± 0.06 11.2 ± 1.1
Values are no. (%) or means(SD)
Patients in group LR received intraoperative placebo Lactate Ringers’ at a dose of 7.5 ml/kg; Patients in group HES received 6% HES 130/0.4 at a dose of 7.5 ml/kg
in the first hour of surgery, and then, Lactate Ringers’ was administrated 5 ml/kg until the end of the surgery. All data were presented as mean ± SD or number of
patients. ASA American Society of Anaesthesiologists, HES 6% hydroxyethyl starch 130/0.4, LR Lactate Ringers
Table 2 Patients’ comorbidities
Comorbidities HES(n = 59) LR(n = 59)
Hypertension,no.(%) 49(83.0) 51(86.4)




COPD chronic obstructive pulmonary disease, CABG coronary artery bypass
graft, HES 6% hydroxyethyl starch 130/0.4, LR Lactate Ringers’
Values are no. (%)
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Conclusion
In summary, the present data asserts that elderly pa-
tients with hip arthroplasty under spinal anesthesia are a
high-risk population for AKI, and the risk of ischemia
should be avoided. Furthermore, elderly patients with
normal renal function receiving a spinal anesthesia for a
short duration surgery would not develop AKI when a
small amount of HES (500 mL) was infused. Yet, caution
must be exercised in translating these results to an aver-
age clinical situation.
Table 3 Intraoperative mean arterial blood pressure and heart rate
Groups MAP(mmHg) HR(beats/min)
T0 T1 T2 T3 T4 T0 T1 T2 T3 T4
HES 112 ± 7 105 ± 6 99 ± 8 100 ± 6 101 ± 7 65 ± 3 68 ± 5 66 ± 4 67 ± 5 63 ± 4
LR 109 ± 5 106 ± 8 98 ± 6 96 ± 7 99 ± 6 70 ± 2 69 ± 3 71 ± 5 66 ± 6 65 ± 3
Patients in group LR received intraoperative placebo Lactate Ringers’ at a dose of 7.5 ml/kg; Patients in group HES received 6% HES 130/0.4 at a dose of 7.5 ml/kg
in the first hour of surgery, and then, Lactate Ringers’ was administrated 5 ml/kg until the end of the surgery. Haemodynamics data was evaluated and recorded
at baseline (T0), before skin incision (T1), skin incision (T2), after skin incision (T3), surgery completed (T4). All data were presented as mean ± SD. HES 6%
hydroxyethyl starch 130/0.4, LR Lactate Ringers’, MAP Mean arterial pressure
Table 4 Renal function
Groups D0 D1 D2 D3 D4
p-NGAL (ng/ml)
HES 4.0 ± 0.3 4.2 ± 0.5 4.3 ± 0.5 4.2 ± 0.5 4.4 ± 0.6
LR 4.1 ± 0.8 4.0 ± 0.7 4.4 ± 0.9 4.1 ± 0.7 4.3 ± 0.8
u-NGAL (ng/ml)
HES 4.9 ± 0.8 5.1 ± 0.3 4.9 ± 0.4 5.2 ± 0.5 5.1 ± 0.4
LR 5.6 ± 0.7 5.2 ± 0.4 4.9 ± 0.3 5.0 ± 0.3 5.1 ± 0.3
p-IL18 (μg/l)
HES 79.3 ± 9.8 81.0 ± 10.4 84.2 ± 13.8 83.4 ± 10.2 85.1 ± 11.3
LR 81.0 ± 14.5 81.4 ± 9.0 83.8 ± 12.5 86.5 ± 14.1 81.5 ± 6.1
u-IL-18 (μg/l)
HES 82.7 ± 8.5 89.5 ± 5.8 109.6 ± 9.2* 140.5 ± 10.9* 159.7 ± 16.9*
LR 86.6 ± 8.5 83.2 ± 4.8 118.5 ± 11.4* 142.6 ± 18.1* 162.0 ± 18.5*
eGFR (ml/min/1.73 m2)
HES 63.9 ± 14.3 63.5 ± 13.5 64 ± 14.7 72.8 ± 10.4 68.6 ± 12.4
LR 61.9 ± 8.3 63.5 ± 9.6 63 ± 6.2 64 ± 9.4 66.4 ± 9.2
ACR
HES 1.96 ± 0.21 1.98 ± 0.19 1.90 ± 0.09 1.99 ± 0.13 1.95 ± 0.20
LR 1.89 ± 0.14 1.84 ± 0.20 1.90 ± 0.19 1.94 ± 0.15 1.92 ± 0.12
u-β2 micro-albumin (mg/l)
HES 96.4 ± 11.2 97.1 ± 12.2 101.7 ± 9.4 99.4 ± 15.7 103.0 ± 13.8
LR 93.2 ± 8.9 90.6 ± 8.2 99.8 ± 14.2 104.7 ± 15.0 93.2 ± 12.3
p-Creatinine (umol/l)
HES 92.5 ± 9.3 94.6 ± 7.9 93.1 ± 9.1 81.2 ± 8.6 85.9 ± 7.7
LR 85.7 ± 5.9 86 ± 9.1 85.3 ± 6.3 85.1 ± 7.9 82.6 ± 9.2
u-Albumin (g/l)
HES 87.4 ± 4.1 90.2 ± 4.3 91.1 ± 5.1 96.1 ± 6.3 97.5 ± 7.0
LR 86.6 ± 5.7 87.1 ± 2.8 92.3 ± 3.8 97 ± 4.7 98.1 ± 6.4
Patients in group LR received intraoperative placebo Lactate Ringers’ at a dose of 7.5 ml/kg; Patients in group HES received 6% HES 130/0.4 at a dose of 7.5 ml/kg
in the first hour of surgery, and then, Lactate Ringers’ was administrated 5 ml/kg until the end of the surgery. Blood and urine sample were got at five time
points: before anaesthesia (D0), during surgery (D1), the first day after surgery (D2), the third day after surgery (D3), the fifth day after surgery (D4). ACR, eGFR,
urine (u) and plasma (p) NGAL, plasma creatinine, urine β2 micro-albumin and albumin were assessed. Values are presented as mean ± SD, *P < 0.05 vs. D0
HES 6% hydroxyethyl starch 130/0.4, LR Lactate Ringers’, u-NGAL urine Neutrophil gelatinase–associated lipocalin, p-NGAL plasma Neutrophil gelatinase–associated
lipocalin, eGFR estimated glomerular filtration rate, ACR ratio of urine trace albumin and urine creatinine
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